Search Count: 22
 |
Crystal Structure Of The Sars-Cov-2 Main Protease Inhibited By (2-Methylsulfanyl-6,7-Dihydro-[1,4]Dioxino[2,3-F]Benzimidazol-3-Yl)-(P-Tolyl)Methanone
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.70 Å Release Date: 2025-01-01 Classification: VIRAL PROTEIN Ligands: 4MA, DMS, GOL, FMT, NA |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2025-01-01
Ligands: 4MA, DMS, GOL, FMT, NA
 |
Sars-Cov-2 Main Protease Complexed With (1R)-N-(3-Chlorophenyl)-3-Oxo-Indane-1-Carboxamide
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2024-11-27 Classification: VIRAL PROTEIN Ligands: DMS, A1ITO, GOL |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2024-11-27
Ligands: DMS, A1ITO, GOL
 |
Sars-Cov-2 Main Protease Complexed With (1R)-N-(3-Chlorophenyl)-3-Oxo-N-[4-(2-Oxopyrrolidin-1-Yl)Phenyl]Indane-1-Carboxamide
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.49 Å Release Date: 2024-11-27 Classification: VIRAL PROTEIN Ligands: A1ITP, DMS, GOL, NA |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2024-11-27
Ligands: A1ITP, DMS, GOL, NA
 |
Sars-Cov-2 Main Protease In Complex With With (1R)-N-(3-Chlorophenyl)-N-[4-(2,4-Dioxo-1H-Pyrimidin-5-Yl)Phenyl]-3-Oxo-Indane-1-Carboxamide
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.70 Å Release Date: 2024-11-27 Classification: VIRAL PROTEIN Ligands: A1ITV, NA |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2024-11-27
Ligands: A1ITV, NA
 |
Sars-Cov-2 Main Protease In Complex With (3S)-3-[(3R)-3-Phenylpiperidine-1-Carbonyl]Indan-1-One
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.79 Å Release Date: 2024-11-27 Classification: VIRAL PROTEIN Ligands: DMS, A1ITW, FMT |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2024-11-27
Ligands: DMS, A1ITW, FMT
 |
Sars-Cov-2 Main Protease In Complex With (3R)-3-[(3R)-4-Benzyl-3-Phenyl-Piperidine-1-Carbonyl]Indan-1-One
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.05 Å Release Date: 2024-11-27 Classification: VIRAL PROTEIN Ligands: A1IT1, FMT |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2024-11-27
Ligands: A1IT1, FMT
 |
Sars-Cov-2 Main Protease In Complex With (1R)-3-Oxo-N-[2-Oxo-2-(N-Phenylanilino)Ethyl]Indane-1-Carboxamide
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.77 Å Release Date: 2024-11-27 Classification: VIRAL PROTEIN Ligands: A1IT2 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2024-11-27
Ligands: A1IT2
 |
Sars-Cov-2 Main Protease Complexed With N-(Pyridin-3-Ylmethyl)Thioformamide
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.83 Å Release Date: 2023-03-15 Classification: VIRAL PROTEIN Ligands: DMS, 35J, NA |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2023-03-15
Ligands: DMS, 35J, NA
 |
Crystal Structure Of The Sars-Cov-2 Main Protease Complexed With N-(Pyridin-3-Ylmethyl)Thioformamide
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.50 Å Release Date: 2022-03-02 Classification: VIRAL PROTEIN Ligands: 35J, NA, FMT, DMS |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2022-03-02
Ligands: 35J, NA, FMT, DMS
 |
Crystal Structure Of The Sars-Cov-2 Main Protease With Oxidized C145
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.48 Å Release Date: 2021-10-06 Classification: VIRAL PROTEIN Ligands: DMS, GOL, FMT |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2021-10-06
Ligands: DMS, GOL, FMT
 |
Crystal Structure Of The Sars-Cov-2 Main Protease Complexed With Fragment F01
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.47 Å Release Date: 2021-10-06 Classification: VIRAL PROTEIN |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2021-10-06
 |
Crystal Structure Of Insulin Degrading Enzyme In Complex With Bdm44768
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.73 Å Release Date: 2015-10-07 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: ZN, 2H7, 1PE, PEG, EDO, EPE, DIO |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2015-10-07
Ligands: ZN, 2H7, 1PE, PEG, EDO, EPE, DIO
 |
Crystal Structure Of Human Insulin Degrading Enzyme (Ide) In Complex With Compound 71290
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.91 Å Release Date: 2015-09-30 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: ZN, 3M9, EPE, PEG, 1PE, EDO |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2015-09-30
Ligands: ZN, 3M9, EPE, PEG, 1PE, EDO
 |
Crystal Structure Of Human Insulin Degrading Enzyme (Ide) In Complex With Inhibitor N-Benzyl-N-(Carboxymethyl)Glycyl-L-Histidine
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:3.20 Å Release Date: 2015-05-13 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: 33K, ZN |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2015-05-13
Ligands: 33K, ZN
 |
Crystal Structure Of Human Insulin Degrading Enzyme (Ide) In Complex With Compound Bdm44619
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:3.29 Å Release Date: 2013-12-18 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: ZN, 1EF |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2013-12-18
Ligands: ZN, 1EF
 |
Structure Analysis Of Cysteine Free Insulin Degrading Enzyme (Ide) With Compound Bdm43079 [{[(S)-2-(1H-Imidazol-4-Yl)-1-Methylcarbamoyl-Ethylcarbamoyl]-Methyl}-(3-Phenyl-Propyl)-Amino]-Acetic Acid
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.99 Å Release Date: 2013-08-28 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: MGJ, ZN |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2013-08-28
Ligands: MGJ, ZN
 |
Structure Analysis Of Insulin Degrading Enzyme With Compound Bdm41559 ((S)-2-[2-(Carboxymethyl-Phenethyl-Amino)-Acetylamino]-3-(1H-Imidazol-4-Yl)-Propionic Acid Methyl Ester)
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.81 Å Release Date: 2013-08-28 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: ZN, MGW |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2013-08-28
Ligands: ZN, MGW
 |
The Structure Analysis Of Cysteine Free Insulin Degrading Enzyme (Ide) With (S)-2-{2-[Carboxymethyl-(3-Phenyl-Propionyl)-Amino]-Acetylamino}-3-(3H-Imidazol-4-Yl)-Propionic Acid Methyl Ester
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.70 Å Release Date: 2013-08-28 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: MGH, ZN |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2013-08-28
Ligands: MGH, ZN
 |
Structure Of Cystein Free Insulin Degrading Enzyme With Compound Bdm41671 ((S)-2-{2-[Carboxymethyl-(3-Phenyl-Propyl)-Amino]-Acetylamino}-3-(1H-Imidazol-4-Yl)-Propionic Acid Methyl Ester)
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:3.00 Å Release Date: 2013-04-03 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: MGK, ZN |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2013-04-03
Ligands: MGK, ZN
 |
Crystal Structure Of Human Insulin Degrading Enzyme (Ide) In Complex With Compund 41367
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:3.22 Å Release Date: 2013-02-27 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: ZN, I41 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2013-02-27
Ligands: ZN, I41